Ke Geng

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

Canan Kasikara, Viralkumar Davra, David Calianese et al. · Cancer Research · 2019 · 132 citations

Medicine, Oncology, Pharmacology +17

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression

Canan Kasikara, Sushil Kumar, Stanley Kimani et al. · Molecular Cancer Research · 2017 · 125 citations · Full text

Medicine, Cancer Biology, Oncology +17

KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition

Yuanwang Pan, Han Han, Hai Hu et al. · Cancer Cell · 2022 · 98 citations · Full text

Medicine, Cancer Biology, Oncology +17

Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Viralkumar Davra, Sushil Kumar, Ke Geng et al. · Cancer Research · 2020 · 95 citations · Full text

Life Sciences, Immunology, Oncology +17

Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6

Ke Geng, Sushil Kumar, Stanley Kimani et al. · Frontiers in Immunology · 2017 · 83 citations · Full text

Life Sciences, Cell Biology, Oncology +14